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LETTERS TO THE EDITOR
Announcement of Protocol Change in
Thrombolysis in Myocardial Infarction Trial
The National Heart. Lung. and Blood Institute' s Thrombolysis in
Myocardial Infarction (TIMO Study has reduced the dose of tissue
plasminogen activator (rt-PA) used from 150 mg over 6 hours to
100 mg over 6 hours. This protocol change was taken after review
and recommendation by an independent Safety and Data Moni-
toring Committee. This recommendation was based in large part
on the occurrence of intracerebral hemorrhage in 5 of 311 patients
(1.6%) during a prerandomization pilot study. Three of these five
events occurred within 24 hours of onset of treatment and three
were fatal during hospitalization. Major hemorrhagic events de-
fined as either intracerebral hemorrhage or a decline in hemoglobin
of ""5 g/dl were observed in 41 of 311 patients (13.2%), However,
the overall in-hospital mortality in this series was 15of 311 (4.8%),
Intracerebral hemorrhage occurred in only I of 386 patients
treated with rt-PA in prior TIMI protocols. All TIMI patients
received full dose heparin anticoagulation in addition to rt-PA
infusion. The etiology of these intracerebral hemorrhages could
be related to multiple factors including prior neurologic disease.
Thrombolytic therapy should be given to individuals only after
careful screening for contraindications such as prior neurologic
events. serious hypertension and potential bleeding sites.
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Genentech Experience With rt-PA (Activase)
467
recommendation that thrombolytic therapy should be initiated only
after careful screening for known risk factors.
Table 1
Production Total Dose No. No. Incidence
Process (rug) Treated ICH (%)
Small scale* 40 to 80 341 0 0
Large scale 80 to 119 251 I 0.4
Large scale 120 to 170 406 2 0.5
Total 998 3 0.3
*The small scale process produced the rt-PA used inTIMI phase I and
the dose of 40 to 80 mg was clinically equivalent to a dose of 80 to 100
mg of the large scale rt-PA which was used in the TIMI open label A
through E. ICH = intracerebral hemorrhage.
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Balloon Selection for Double
Balloon Valvotomy
The recent article by Radtkeet al. ( I) describing balloon valvotomy
using oversized balloons proposes the use of an "effective dilation
diameter" for the double balloon technique. The calculations equate
the area of the "oval" enveloping the two balloons with a hy-
pothetical single balloon of larger diameter. It would seem more
appropriate to recognize that. whereas the perimeter of the pul-
monary valve anulus is relatively fixed, the cross-sectional area is
not. Balloon selection should therefore be based on an equivalent
perimeter (Penv), which would result in a somewhat different for-
mula. Using the nomenclature proposed by Radtke (Fig. 6 in Ref.
IJ. the "effective dilation diameter" (den) would equal
r.,
dell = -.
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Table I. Effective Dilation Diameter for
Various Dilation Balloon Combinations
In the light of the observations reported by the investigators of the
TIMI trialof the National Heart. Lung. and BloodInstitute (NHLBI).
we have reviewed our experience with the use of rt-PA in myo-
cardial infarction with specific reference to the incidence of intra-
cerebral hemorrhage in the 48 hours after infusion of rt-PA. This
experience includes studies conducted in Europe as well as those
conducted in the United States. exclusive of the NHLBI TIMI trial
(Table 1).
The overall incidence of intracerebral bleeding was 0.3% (3 of
998 patients) with one fatality. Over 400 patients have been treated
at a dose (120 to 170 mg) and duration (3 to 8 hours) comparable
with the regimen used in TIMI open label E and only 2 had
intracerebral bleeding (0.5%). We nevertheless agree with the
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Balloon Diameter (rnrn)
12 15 18 20
19.6 22.1 248 26.5
22.1 24.6 27.1 28.8
24.8 27.1 29.5 31.1
26.5 28.8 31. J 32.7
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and
Using this formula, the delT of various combinations of commonly
used balloons is shown in Table I. The area method consistently
results in an underestimation of deff by approximately I to 3 mm.
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Reply
We have considered Yeager' s suggestion about calculation of ef-
fective dilating diameter carefully and have concluded that he is.
in fact. correct. The assumption should be made of constant pe-
rimeter rather than constant area. Indeed, we have incorporated
his suggestions into our own use of the double balloon technique.
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Quantitative Morphology of the Aortic Arch
Morrow et al. (I) recently presented quantitative echocardio-
graphic data concerning the morphology of the aortic arch in neo-
natal coarctation. They misquote the fundamental segmental mea-
surements of the thoracic aorta introduced by Sinha et al. (2) in
1969. They also neglect to refer to a recent morphometric study
of the aortic arch (3) that is similar in design and results and is
based on extensive echocardiographic (n = 70) and angiographic
(n = 91) measurements.
Sinha et al. (2) present both in the text (p. 386) and in Figure
3 (p. 387) a quantitative classification and discriminant function
analysis of aortic arch pathology based on measurements of the
transverse arch and descending aorta, and not the " pulmonary
valve dimension" as stated by Morrow et al. ( I) (p. 619).
Lappen et al. (3) presented echocardiographic and angiographic
data indicating specifically that hypoplasia of the transverse aortic
arch (TAA) is almost universally present incoarctation of the aorta,
and importantly, persists long after the neonatal period (body sur-
face area 0.2 to 1.4 rn"). Lappen et al. (3) further introduced the
diameter of the left common carotid artery (LCCA) as a norm
against which the diameter of the transverse aortic arch can be
quantitated. There is indeed no appreciable difference between the
quantitative data of Lappen et al. (3) for the LCCArfAA mea-
surements (0.84 ± 0.10 for coarctation versus 0.55 ± 0.03 for
normal controls by echocardiography, and 0.83 ± 0.14 for coarc-
tation versus 0.45 ± 0.12 for normalcontrols by cineangiography)
and the same measurements of Morrow et al. ( I) (LCCAITAA of
0.96 :t 0.18 for coarctation versus 0.48 ± 0.08 for normal con-
trols). Furthermore, Lappen et al. (3) found the same LCCAITAA
ratio in patients who had coarctation and a large ventricular septal
defect. Transverse aortic arch hypoplasia could not be demon-
strated in patients with a large left to right shunt or other significant
defects who had no associated coarctation of the aorta.
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Reply
The hypothesis in our study was that measurements of the great
arteries were a reflection of intrauterine blood flow relations and
that coarctation was associated with redistribution of blood flow
in utero. This hypothesis was supported by the finding that trans-
verse arch hypoplasia with dilation of the pulmonary artery was
present with coarctation. Once significant systemic hypertension
results from coarctation. the presumption that structure size is a
reflection of blood flow is not valid and therefore we excluded all
patients older than I month of age. Our study clarifies the cause
for the right ventricular preponderance and right ventricular hy-
pertrophy on the electrocardiogram with coarctation of the aorta
despite relatively low pulmonary artery pressures, which were
described as a "misleading reflection of the physiologic status"
by Sinha et al. Right ventricular hypertrophy is present because
of the marked increase in right ventricular stroke work, which is
secondary to aortic arch obstruction in utero. We appreciate the
information of Lappen et al., but it was not included in our dis-
cussion because of differences in methodology-namely the use
of the left carotid artery to normalize the measurements by angi-
ography and echocardiography. Perhaps the most important finding
of our study was the increase in the size of the left carotid artery
in neonates with coarctation compared with normal subjects, sug-
gesting increased carotid blood flow in utero and immediately after
birth. We speculate that cerebral complications of coarctation late
in life may be due, in part, to increased cerebral blood flow in
utero. Hypoplasia should not be viewed as a separate diagnosis
and almost never requires surgical treatment. It is simply a re-
flection of altered blood flow relations in the developing great
arteries in fetuses with coarctation of the aorta.
JAMES C. HUHTA, MD, FACC
Pediatric Cardiology 1-253
Texas Children' s Hospital
6621 Fannin Street
Houston, Texas 77030
